Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Long-term Safety and Clinical Activity in Patients with Conventional Chondrosarcoma.
Saved in:
| Title: | Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Long-term Safety and Clinical Activity in Patients with Conventional Chondrosarcoma. |
|---|---|
| Authors: | Tap WD; Memorial Sloan Kettering Cancer Center, New York, New York., Cote GM; Mass General Cancer Center, Boston, Massachusetts., Burris H; Sarah Cannon Research Institute, Nashville, Tennessee., Gore L; University of Colorado School of Medicine and University of Colorado Cancer Center, Aurora, Colorado., Elias A; University of Colorado School of Medicine and University of Colorado Cancer Center, Aurora, Colorado., Beeram M; START Center for Cancer Care, San Antonio, Texas., Conley AP; MD Anderson Cancer Center, Houston, Texas., Gianolio DA; Servier Bio-Innovation, Boston, Massachusetts., Qu Z; Servier Bio-Innovation, Boston, Massachusetts., Pandya S; Servier Bio-Innovation, Boston, Massachusetts., Trent JC; Sylvester Comprehensive Cancer Center, Miami, Florida. |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Jun 03; Vol. 31 (11), pp. 2108-2114. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Multicenter Study |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40100120 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Long-term Safety and Clinical Activity in Patients with Conventional Chondrosarcoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tap+WD%22">Tap WD</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Cote+GM%22">Cote GM</searchLink>; Mass General Cancer Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Burris+H%22">Burris H</searchLink>; Sarah Cannon Research Institute, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Gore+L%22">Gore L</searchLink>; University of Colorado School of Medicine and University of Colorado Cancer Center, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Elias+A%22">Elias A</searchLink>; University of Colorado School of Medicine and University of Colorado Cancer Center, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Beeram+M%22">Beeram M</searchLink>; START Center for Cancer Care, San Antonio, Texas.<br /><searchLink fieldCode="AU" term="%22Conley+AP%22">Conley AP</searchLink>; MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Gianolio+DA%22">Gianolio DA</searchLink>; Servier Bio-Innovation, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Qu+Z%22">Qu Z</searchLink>; Servier Bio-Innovation, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Pandya+S%22">Pandya S</searchLink>; Servier Bio-Innovation, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Trent+JC%22">Trent JC</searchLink>; Sylvester Comprehensive Cancer Center, Miami, Florida. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2025 Jun 03; Vol. 31 (11), pp. 2108-2114. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40100120 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/1078-0432.CCR-24-4128 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2108 Titles: – TitleFull: Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Long-term Safety and Clinical Activity in Patients with Conventional Chondrosarcoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tap WD – PersonEntity: Name: NameFull: Cote GM – PersonEntity: Name: NameFull: Burris H – PersonEntity: Name: NameFull: Gore L – PersonEntity: Name: NameFull: Elias A – PersonEntity: Name: NameFull: Beeram M – PersonEntity: Name: NameFull: Conley AP – PersonEntity: Name: NameFull: Gianolio DA – PersonEntity: Name: NameFull: Qu Z – PersonEntity: Name: NameFull: Pandya S – PersonEntity: Name: NameFull: Trent JC IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 06 Text: 2025 Jun 03 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1557-3265 Numbering: – Type: volume Value: 31 – Type: issue Value: 11 Titles: – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research Type: main |
| ResultId | 1 |